1
|
Lejding T, Persson L, Andersen KE, Bruze M, Derevyanko L, Elsner P, Goh CL, Gonçalo M, Goossens A, Gülgün MA, Isaksson M, Ljubojevic Hadzavdic S, Maibach H, Matsunaga K, Mowitz M, Nixon R, Pailin P, Pratt M, Schuttelaar MLA, Sukakul T, Verma K, Zimerson E, Özkaya E, Svedman C. Analysis of Hexavalent Chromium in Cement Samples From Countries Within and Outside the EU: A Study From the International Contact Dermatitis Research Group. Dermatitis 2023; 34:323-328. [PMID: 37001151 DOI: 10.1089/derm.2022.0053] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/03/2023]
Abstract
Background: Allergic contact dermatitis (ACD) caused by hexavalent chromium (Cr(VI)) is often severe and difficult to treat. The content of Cr(VI) in cement can be reduced by, for example, addition of iron(II) sulfate. Since 2005 the content of Cr(VI) in cement is regulated in the EU Directive 2003/53/EC and must not exceed 2 ppm. Since this regulation came into force, ACD caused by cement has markedly been reduced. Objective: To investigate Cr(VI) and total chromium content in samples of cement from countries within and outside the EU. Methods: The members of the International Contact Dermatitis Research Group (ICDRG) were invited to participate in the study with the aim to collect cement samples from geographically different areas. The content of Cr(VI) in the samples was estimated by the diphenyl carbazide spot test, atomic absorption spectroscopy was used to assess the total chromium content. Results: Forty-five cement samples were analyzed, containing amounts of Cr(VI) from <0.1 to >70 ppm. Twenty-one samples contained >2 ppm Cr(VI), 24 contained less. Four of 17 samples from within the EU contained >2 ppm Cr(VI), that is, higher amounts than stipulated in the EU directive, as compared with 17 samples from countries outside the EU. Conclusion: In countries outside the EU, significantly more cement samples contained >2 ppm Cr(VI).
Collapse
Affiliation(s)
- Tina Lejding
- From the Department of Occupational and Environmental Dermatology, Skåne University Hospital, Lund University, Malmö, Sweden
| | - Lena Persson
- From the Department of Occupational and Environmental Dermatology, Skåne University Hospital, Lund University, Malmö, Sweden
| | - Klaus Ejner Andersen
- Department of Dermatology, Odense University Hospital, University of Southern Denmark, Odense, Denmark
| | - Magnus Bruze
- From the Department of Occupational and Environmental Dermatology, Skåne University Hospital, Lund University, Malmö, Sweden
| | - Ludmyla Derevyanko
- Department of Dermatovenereology, Kyiv Medical University, Kyiv, Ukraine
| | - Peter Elsner
- Department of Dermatology, University Hospital Jena, Jena, Germany
| | | | - Margarida Gonçalo
- University Hospital and Faculty of Medicine University of Coimbra, Coimbra, Portugal
| | - An Goossens
- Department of Dermatology, KU Leuven, Leuven, Belgium
| | - Mehmet Ali Gülgün
- Sabancı University, Faculty of Engineering and Natural Sciences Materials Science and Nano Engineering, Tuzla-Istanbul, Turkey
| | - Marléne Isaksson
- From the Department of Occupational and Environmental Dermatology, Skåne University Hospital, Lund University, Malmö, Sweden
| | - Suzana Ljubojevic Hadzavdic
- Department of Dermatovenereology, University Hospital Center Zagreb, University of Zagreb, School of Medicine, Kišpatićeva, Zagreb, Croatia
| | - Howard Maibach
- Department of Dermatology, University of California Medical Center, San Francisco, California, USA
| | - Kayoko Matsunaga
- Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Nagoya, Japan
| | - Martin Mowitz
- From the Department of Occupational and Environmental Dermatology, Skåne University Hospital, Lund University, Malmö, Sweden
| | - Rosemary Nixon
- Occupational Dermatology Research and Education Centre, Skin Health Institute, Carlton, Melbourne, Victoria, Australia
| | | | - Melanie Pratt
- University of Ottawa, The Ottawa Hospital, Ottawa, Canada
| | | | - Thanisorn Sukakul
- From the Department of Occupational and Environmental Dermatology, Skåne University Hospital, Lund University, Malmö, Sweden
| | - Kaushal Verma
- Department of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi, India
| | - Erik Zimerson
- From the Department of Occupational and Environmental Dermatology, Skåne University Hospital, Lund University, Malmö, Sweden
| | - Esen Özkaya
- Department of Dermatology and Venereology, Istanbul University, Istanbul Faculty of Medicine, Çapa-Istanbul, Turkey
| | - Cecilia Svedman
- From the Department of Occupational and Environmental Dermatology, Skåne University Hospital, Lund University, Malmö, Sweden
| |
Collapse
|
12
|
Abstract
The present studies concerned 31 work sites in eight factories at which 422 persons were employed. In the course of seven years there were 126 cases of dermatitis, 99 of whom were patch-tested. Positive reactions to epoxy resin and/or to triethylenetetramine were found in 65.7% of the subjects. The aetiology of the other cases is discussed. Some of the patients who were positive to epoxy resin were tested with Bisphenol A and modified resins with blocked epoxy groups. The latency period of dermatitis and the localization were recorded, as well as the influence of the season and of certain working conditions on the occurrence of sensitization. Of the 80 patients who changed their occupation, there were relapses in 50 within one year. Relapses were more frequent in persons who continued to work with epoxy resins for more than three months after the appearance of dermatitis and in those simultaneously sensitive to allergens in the standard series.
Collapse
|